Leal Julie N, Sadot Eran, Gonen Mithat, Lichtman Stuart, Kingham T Peter, Allen Peter J, DeMatteo Ronald P, Jarnagin William R, D'Angelica Michael I
Department of Surgery, Memorial Sloan Kettering Cancer Center, USA.
Department of Epidemiology/Biostatistics, Memorial Sloan Kettering Cancer Center, USA.
HPB (Oxford). 2017 Feb;19(2):162-169. doi: 10.1016/j.hpb.2016.09.009. Epub 2016 Nov 30.
Clinical outcomes of octogenarians undergoing hepatectomy for colorectal liver metastases (CRLM) are poorly characterized. The current study evaluated operative morbidity, mortality and survival outcomes among a contemporary cohort of octogenarians.
Patients undergoing their first hepatectomy for CRLM were identified from institutional databases and those ≥80 years old (y) were matched 1:1 to a group of patients <80 y. Data pertaining to surgical morbidity/mortality and survival were compared using standard statistical methods.
From 2002 to 2012, 1391 hepatectomies were performed for CRLM, 55 (4%) in patients ≥80 y. Major complications occurred twice as frequently among patients ≥80 y [10 (19%) ≥80 y versus 5 (9%) <80 y, (p = 0.270)]. No matched patient <80 y. died within 90 d of operation, whereas, 4 (7%) patients ≥80 y did, p = 0.125. Median follow-up was significantly longer for the <80 y group [44 (1-146) versus. 23 (0-102) mths, p = 0.006]. Probability of disease recurrence was not different between groups (p = 0.123) nor was the cumulative incidence of death from disease (p = 0.371). However, patients ≥80 y had significantly higher incidence of non-cancer related death (p = 0.012).
Hepatectomy for CRLM among well-selected octogenarians is reasonable with cancer related survival outcomes similar to those observed in younger patients. However, it is associated with clinically significant morbidity/mortality and continued efforts directed at optimizing perioperative care are necessary to improve early outcomes among octogenarians.
八旬老人接受肝切除术治疗结直肠癌肝转移(CRLM)的临床结果鲜有描述。本研究评估了当代八旬老人队列中的手术并发症、死亡率和生存结果。
从机构数据库中识别出首次接受CRLM肝切除术的患者,并将年龄≥80岁(y)的患者与一组年龄<80岁的患者进行1:1匹配。使用标准统计方法比较手术并发症/死亡率和生存相关数据。
2002年至2012年,共进行了1391例CRLM肝切除术,其中55例(4%)患者年龄≥80岁。年龄≥80岁的患者发生主要并发症的频率是年龄<80岁患者的两倍[年龄≥80岁患者为10例(19%),年龄<80岁患者为5例(9%),(p = 0.270)]。年龄<80岁的匹配患者在术后90天内无死亡,而年龄≥80岁的患者有4例(7%)死亡,p = 0.125。年龄<80岁组的中位随访时间显著更长[44(1 - 146)个月对23(0 - 102)个月,p = 0.006]。两组之间疾病复发的概率无差异(p = 0.123),疾病导致的累积死亡率也无差异(p = 0.371)。然而,年龄≥80岁的患者非癌症相关死亡的发生率显著更高(p = 0.012)。
精心挑选的八旬老人接受CRLM肝切除术是合理的,其癌症相关生存结果与年轻患者相似。然而,该手术与具有临床意义的并发症/死亡率相关,需要持续努力优化围手术期护理,以改善八旬老人的早期结局。